Remembering Rachna Shroff: The Sunshine She Leaves Behind
ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes
What Comes Next? Treatment Sequencing in Advanced Urothelial Carcinoma
Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy
Victor Moreno: Tumor Growth vs Antitumor Immunity, A New Strategy to Fight MSS Colorectal Cancer
Christopher Jackson: Humbled and Honoured to Receive the HRC’s Beaven Medal
"Stronger Regions, Stronger Countries..." - Dr Gevorg Tamamyan
Natalia Vilcu-Bajurean at LeukO 2026: A Mother's Powerful Promise to Change Childhood Cancer Care
The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2, 2026, in Lugano, Switzerland. This intensive program is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endometrial cancer, from diagnosis and pathology to advanced therapeutic strategies. Key learning objectives typically include exploring the […]
The ESMO Gastrointestinal Cancers Congress 2026 will be held from 1 to 4 July in Munich, Germany, and online. This major event brings together global experts, researchers, and healthcare professionals focused on improving prevention, diagnosis, and treatment across the full spectrum of gastrointestinal cancers. With a programme featuring expert-led discussions, tumour boards, clinical debates, and […]
The ESMO Preceptorship on Endocrine Tumours 2026: Lugano is scheduled for July 8–9, 2026, in Lugano, Switzerland. Co-chaired by Alfredo Berruti and Rocio Garcia-Carbonero, this intensive educational course is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endocrine neoplasms. The curriculum typically focuses on the latest standards of care, […]
ESMO Preceptorship on Breast Cancer 2026 will take place from 10 Jul 2026 to 11 Jul 2026 in Munich, Germany, under the leadership of Co-Chairs Nadia Harbeck (Munich, Germany) and Peter Schmid (United Kingdom). The program is designed to enable the interdisciplinary discussion and collaboration in the care of patients with breast cancer, to understand […]
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by the European Society for Medical Oncology (ESMO), the course is specifically designed for fourth and fifth-year medical students. Co-Chaired by Andrés Cervantes and Rodrigo Sanchez […]
The ESMO Academy 2026, organized by the European Society for Medical Oncology (ESMO), will take place virtually from 3 August to 12 October 2026. The programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty, covering major tumour types, clinical trial methodology, treatment principles, pharmacokinetics, drug interactions, and topics relevant to […]
The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar, organized by the European Society for Medical Oncology (ESMO), will take place live on 2 September 2026 at 18:30 CEST. The session will examine the reliability of current HRD testing, the role of PARP inhibitors in maintenance therapy, and the emerging potential […]
The “Optimising Antibody–Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities 2026” webinar, organized by the European Society for Medical Oncology (ESMO), will take place on September 9, 2026, at 6:30 PM CEST (8:30 PM AMT). Part of the ESMO Therapeutic Landscapes series, the session will focus on recognising, preventing, and managing toxicities associated with […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 in London, United Kingdom. This high-level, two-day meeting will serve as a platform for experts in oncology, molecular diagnostics, and precision medicine to converge and […]
The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich, Switzerland, from September 18–19, 2026. Chaired by Natalie Cook and Benedikt Westphalen, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases, from diagnosis to treatment, according to current […]
The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 29–30 September 2026 in Lugano, Switzerland. The course will focus on managing cancer-related symptoms, cachexia, nutritional needs, treatment toxicities, palliative care, end-of-life preparation, and communication with patients and […]
The ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday, September 30, 2026, starting at 18:30 CEST. As uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens […]
The ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026, organized by the European Society for Medical Oncology (ESMO), will take place on September 30, 2026, at 6:30 PM CEST (8:30 PM AMT). The webinar will review the latest evidence-based recommendations for early-stage and locally advanced non-small-cell lung cancer (NSCLC), […]
The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on treatment sequencing, the biology of metastatic breast cancer, targeted therapy safety and adverse-event management, and multidisciplinary approaches to improving […]
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. The course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC, biomarker-driven treatment using NGS, immunohistochemistry, and liquid biopsy, and emerging therapies such as […]
The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026, organized by the European Society for Medical Oncology (ESMO), will take place on October 7, 2026, at 6:30 PM CEST (8:30 PM AMT). This live educational webinar will examine how new concepts and therapeutic strategies are reshaping […]
